Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
AVEDRO INC (AVDR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/21/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
11/18/2019 |
8-K
| Quarterly results |
11/08/2019 |
8-K
| Other Events |
11/06/2019 |
8-K
| Quarterly results |
08/07/2019 |
8-K
| Quarterly results |
05/09/2019 |
8-K
| Quarterly results |
03/21/2019 |
8-K
| Quarterly results
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : March 21, 2019 Avedro, Inc. Delaware 001-38809 13-4223265 201 Jones Road Waltham, Massachusetts 02451 Registrant's telephone number, including area code: 768-3400 Not applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement c...",
"Avedro, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Financial Outlook WALTHAM, Mass., March 21, 2019 - Avedro, Inc. , a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses, today reported financial results for the quarter and full year ended December 31, 2018. Recent Highlights" |
|
02/19/2019 |
8-K
| Quarterly results |
|
|